You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Molecular therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab injection
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 20, 2023

Molecular Culture for the Diagnosis of Pediatric Sepsis

Not yet recruiting
  • Sepsis
  • +5 more
  • Molecular Culture
  • (no location specified)
Aug 29, 2023

Immune Checkpoint Inhibitor Monotherapy or Combined With

Not yet recruiting
  • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023

Sepsis Trial (Change of antimicrobials based on BCID2 and Reveal Rapid AST tests. Stop of antimicrobials based on PCT results.,

Not yet recruiting
  • Sepsis
  • Change of antimicrobials based on BCID2 and Reveal Rapid AST tests. Stop of antimicrobials based on PCT results.
  • Standard of Care
  • (no location specified)
Jun 22, 2023

Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma

Not yet recruiting
  • Stage IVA Nasopharyngeal Carcinoma
  • Intensity modulated radiation therapy (IMRT) combined with chemotherapy
  • Nanjing, China
    Jiangsu Cancer Hospital
Jun 21, 2023

Next-Generation-Sequencing Trial (Molecular genetic diagnostic)

Not yet recruiting
  • Next-Generation-Sequencing
  • Molecular genetic diagnostic
  • (no location specified)
May 12, 2023

Helicobacter Pylori Infection Trial in Hangzhou (Rabeprazole, Colloidal Bismuth Pectin Granules, Amoxicillin)

Not yet recruiting
  • Helicobacter Pylori Infection
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University, School of Med
Jan 30, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Cardiovascular Risk Trial in Petaling Jaya (Plant Omega, Dietary therapy only)

Not yet recruiting
  • Cardiovascular Risk
  • Plant Omega
  • Dietary therapy only
  • Petaling Jaya, Selangor, Malaysia
    Beacon Hospital Sdn Bhd
May 21, 2023

Molecular Testing for MD Anderson Cancer Center Personalized

Recruiting
  • Glioma
  • +4 more
  • Biospecimen Collection
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)

Not yet recruiting
  • HR+/HER2-breast Cancer
  • Standard endocrine therapy plus Apatinib
  • (no location specified)
Jun 2, 2023

Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular

Completed
Has Results
  • Gliosarcoma
  • Recurrent Glioblastoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 5, 2022

Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 31, 2023

Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Later-line therapy
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 10, 2023

Pancreatic Cancer, Locally Advanced Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • Locally Advanced
  • Later-line therapy
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023

Vital Pulp Therapy Trial in Mansoura (Pulp therapy, Cytokines level in pulpal blood.)

Completed
  • Vital Pulp Therapy
  • Pulp therapy
  • Cytokines level in pulpal blood.
  • Mansoura, Dakahliya, Egypt
    Mansoura University
Jul 18, 2022

Crohn's Disease, Ulcerative Colitis Trial (Samples)

Not yet recruiting
  • Crohn's Disease
  • Ulcerative Colitis
  • Samples
  • (no location specified)
Feb 8, 2023

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

Not yet recruiting
  • Extramedullary Myeloma
  • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Dec 18, 2022

Pancreatic Cancer, Resectable Carcinoma Trial in Beijing (Later-line therapy)

Recruiting
  • Pancreatic Cancer
  • Resectable Carcinoma
  • Later-line therapy
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Apr 10, 2023

Patients With Advanced Refractory Solid Tumors

Not yet recruiting
  • Feasibility
  • +3 more
  • Targeted therapy
  • (no location specified)
Dec 14, 2021

Postoperative Peritonitis Trial in France (rapid molecular diagnosis, conventional method analysis)

Recruiting
  • Postoperative Peritonitis
  • rapid molecular diagnosis
  • conventional method analysis
  • Amiens, France
  • +6 more
Jan 12, 2023

Vitiligo, Dermatology/Skin - Other Trial in Baltimore (Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet)

Active, not recruiting
  • Vitiligo
  • Dermatology/Skin - Other
  • Phototherapy (NB-UVB) via the 3 Series PC & SP phototherapy cabinet
  • Baltimore, Maryland
    Johns Hopkins Outpatient Center
Jun 28, 2022

Molecular Breath Patterns in Patients With OSA

Recruiting
  • Obstructive Sleep Apnea
  • No intervention
  • Zurich, Switzerland
    University Hospital Zurich
May 19, 2022